Please login to the form below

Not currently logged in
Email:
Password:

IMI picks Ipsen's Marc de Garidel to chair governing board

He takes over from former UCB CEO Roch Doliveux

Ipsen Marc de Garidel IMI Innovative Medicines InitiativeThe Innovative Medicines Initiative (IMI) has picked Ipsen's Marc de Garidel to take over as chair of its governing board from Roch Doliveux, who retired as CEO of UCB at the end of 2014.

De Garidel has been chairman and CEO of Ipsen, which specialises in neurology, endocrinology and urology-oncology, since 2010 and he chaired the European Biopharmaceutical Enterprises Association from 2010-12.

Prior to joining Ipsen he served as general manager of Amgen's French affiliate and before Amgen he held various, mainly financial roles, at Lilly.

Commenting on his appointment to the IMI de Garidel said: “I am honoured to represent the healthcare industry in the biggest public-private partnership in life sciences in Europe to date and I am convinced the IMI 2 has a real potential to tackle Europe's growing health challenges and deliver innovation for patients by working together and building on previous successes.”

The IMI is a public-private partnership between the European Union and European pharma body EFPIA and its governing board is the IMI's main decision-making body. Its second-phase IMI 2 programme aims to develop next generation vaccines, medicines and treatments, such as new antibiotics.

Irene Norstedt, IMI acting executive director, said: “IMI is delighted to welcome Marc de Garidel as chair of the governing board. I am confident that his decades of experience working in the pharmaceutical sector will prove invaluable to IMI.”

27th March 2015

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...
Employee engagement
Route 66: can remote working put two-thirds of us back on the road to engaged employment?
Pre-pandemic, 66% of the world’s workforce weren’t engaged in their jobs – Chris Ross examines how the rush to remote working has impacted employee engagement...
Demonstrating the value of HCP self-serve portals
Develop the art of setting KPIs and metrics aligned to your specific objectives, target personas, key educational messages, content, website features and journeys....

Infographics